Dan Wahrenberg

Dan Wahrenberg discloses dealings in 2 companies, chiefly Lifeassays AB and Lifeassays. In total, 6 filings cover trades dated from 2 January 2017 to 17 August 2018.

In open-market terms, that means 4 purchases worth €8,457 on one side and 2 sales worth €5,580 on the other. Purchases outweigh sales by €2,877. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2018 to date brings 1 purchase and 2 sales.

In size, the median ticket on the buying side is €1,316. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 21 August 2018, the filings show an open-market sale worth €2,496 in Lifeassays. The last purchase on record was published on 6 July 2018, which is 3,047 days ago. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.